Patent US4397844A successfully refreshed from Google Patents.
US4397844A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Antigen derivatives and processes for their preparation
Assignee: Novartis Corp
•
Filing: 1981-09-17
•
Granted: 1983-08-09
•
Expires: 2001-09-17
Abstract
Abstract The invention relates to novel antigen derivatives comprising an antigen and at least one muramylpeptide covalently bonded thereto, if appropriate via a spacer, to pharmaceutical preparations which contain such compounds and to their use as a vaccine. The novel antigen derivatives produce a pronounced increase in the immuno-response to the antigen, and in particular also a cell-medicated immunity under clinically acceptable conditions of administration.
Inventors
- 👤 Gerhard Baschang
- 👤 Felix M. Dietrich
- 👤 Roland Gisler
- 👤 Albert Hartmann
- 👤 Jaroslav Stanek
- 👤 Lajos Tarcsay
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 04:08
CPC Classifications
C; C07; C07H; C07H9/00; C07H9/02; C07H9/04; A; A61; A61K; A61K39/00; A61K39/385; C07H23/00; C07K; C07K9/00; C07K9/001; C07K9/005; A61K2039/555; A61K2039/55511; A61K2039/55583; A61K2039/60; A61K2039/6031; A61K2039/6062; Y; Y02; Y02A; Y02A50/00; Y02A50/30; Y10; Y10S; Y10S530/00; Y10S530/806; Y10S530/807
Claims Analysis
Total Claims: 25
Claim 1
Independent Claim
378 words
A compound of the formula I ##STR10## in which X is a carbonyl group, R 1 , R 4 and R 6 independently of one another represent hydrogen tri-lower alkyl-silyl, alkyl having from 1 to 18 carbon atoms, benzyl which is unsubstituted or substituted in the aromatic nucleus by lower alkyl, hydroxyl, lower alkoxy, lower alkylenedioxy, mercapto, lower alkylmercapto, trifluoromethyl and/or halogen, or represent alkanoyl having from 2 to 18 carbon atoms, benzoyl or naphthoyl which are unsubstituted or substituted by halogen, lower alkyl, lower alkoxy, trifluoromethyl, hydroxyl or lower alkanoyloxy, or represent an acyl radical of a lower alkanesulfonic acid or of phenylsulfonic acid, which is unsubstituted or substituted by lower alkyl or halogen, or represent carbamoyl, lower alkyl-carbamoyl or phenyl-carbamoyl, R 2 represents alkyl having 1 to 18 carbon atoms which is unsubstituted or substituted by hydroxy, lower alkoxy, lower alkanoyloxy, halogen, mercapto, lower alkylmercapto, lower alkanoylmercapto, carboxy, lower alkoxycarbonyl and/or carbamoyl, or represents phenyl which is unsubstituted or substituted by lower alkyl, hydroxy, lower alkoxy, lower alkanoyl, lower alkylenedioxy, halogen and/or trifluoromethyl, R 3 represent hydrogen or lower alkyl, at least one of the radicals R 7 , R 9 and R 13 represents lower alkyl, and the others represent hydrogen, R 8 is hydrogen, lower alkyl which is unsubstituted or substituted by hydroxy, lower alkoxy, lower alkanoyloxy, mercapto, lower alkylmercapto, lower alkanoylmercapto, amino, lower alkanoylamino, carbamoylamino or cycloalkyl having 5 or 6 carbon atoms, or represents cycloalkyl-lower alkyl having 5 or 6 carbon atoms, in the cyclic moiety, phenyl or phenyl-lower alkyl, in which the phenyl radicals are unsubstituted or substituted as defined above, or heterocyclyl or heterocyclyl-lower alkyl wherein the heterocyclyl radicals are 5- or 6-membered, contain one or two nitrogen atoms in the ring and may or may not contain a fused phenyl radical, R 7 and R 8 together can also represent alkylene having 3 or 4 carbon atoms, R 10 , R 11 and R 12 independently of one another represent carboxyl, lower alkoxycarbonyl or carbamoyl which is unsubstituted or mono- or disubstituted at the nitrogen atom by unsubstituted, or carboxy- or carbamoyl-substituted, lower alkyl or by phenyl, benzyl, tetramethylene or pentamethylene or R 11 can also be hydrogen, or a salt of such a compound having a salt-forming group.
Claim 2
Dependent Claim
378 words
A compound of the formula I ##STR10## in which X is a carbonyl group, R 1 , R 4 and R 6 independently of one another represent hydrogen tri-lower alkyl-silyl, alkyl having from 1 to 18 carbon atoms, benzyl which is unsubstituted or substituted in the aromatic nucleus by lower alkyl, hydroxyl, lower alkoxy, lower alkylenedioxy, mercapto, lower alkylmercapto, trifluoromethyl and/or halogen, or represent alkanoyl having from 2 to 18 carbon atoms, benzoyl or naphthoyl which are unsubstituted or substituted by halogen, lower alkyl, lower alkoxy, trifluoromethyl, hydroxyl or lower alkanoyloxy, or represent an acyl radical of a lower alkanesulfonic acid or of phenylsulfonic acid, which is unsubstituted or substituted by lower alkyl or halogen, or represent carbamoyl, lower alkyl-carbamoyl or phenyl-carbamoyl, R 2 represents alkyl having 1 to 18 carbon atoms which is unsubstituted or substituted by hydroxy, lower alkoxy, lower alkanoyloxy, halogen, mercapto, lower alkylmercapto, lower alkanoylmercapto, carboxy, lower alkoxycarbonyl and/or carbamoyl, or represents phenyl which is unsubstituted or substituted by lower alkyl, hydroxy, lower alkoxy, lower alkanoyl, lower alkylenedioxy, halogen and/or trifluoromethyl, R 3 represent hydrogen or lower alkyl, at least one of the radicals R 7 , R 9 and R 13 represents lower alkyl, and the others represent hydrogen, R 8 is hydrogen, lower alkyl which is unsubstituted or substituted by hydroxy, lower alkoxy, lower alkanoyloxy, mercapto, lower alkylmercapto, lower alkanoylmercapto, amino, lower alkanoylamino, carbamoylamino or cycloalkyl having 5 or 6 carbon atoms, or represents cycloalkyl-lower alkyl having 5 or 6 carbon atoms, in the cyclic moiety, phenyl or phenyl-lower alkyl, in which the phenyl radicals are unsubstituted or substituted as defined above, or heterocyclyl or heterocyclyl-lower alkyl wherein the heterocyclyl radicals are 5- or 6-membered, contain one or two nitrogen atoms in the ring and may or may not contain a fused phenyl radical, R 7 and R 8 together can also represent alkylene having 3 or 4 carbon atoms, R 10 , R 11 and R 12 independently of one another represent carboxyl, lower alkoxycarbonyl or carbamoyl which is unsubstituted or mono- or disubstituted at the nitrogen atom by unsubstituted, or carboxy- or carbamoyl-substituted, lower alkyl or by phenyl, benzyl, tetramethylene or pentamethylene or R 11 can also be hydrogen, or a salt of such a compound having a salt-forming group.
Claim 3
Dependent Claim
30 words
Compounds of the formula I according to claim 1, in which at least one of the radicals R 7 , R 9 and R 13 represents methyl, and salts thereof.
Claim 4
Dependent Claim
71 words
Compounds of the formula I according to claim 1, in which R 1 , R 4 , R 6 , R 11 and R 13 represent hydrogen, R 2 represents methyl or phenyl, R 3 represents hydrogen or methyl, R 7 represents methyl, ethyl or propyl, R 8 represents hydrogen, methyl or ethyl, R 9 represents hydrogen or methyl, R 10 represents carbamoyl and R 12 represents carboxy, and salts thereof.
Claim 5
Dependent Claim
24 words
Compounds of the formula I according to claim 1, in which R 7 represents lower alkyl and R 13 represents hydrogen, and salts thereof.
Claim 6
Dependent Claim
18 words
Compounds of the formula I according to claim 4, in which R 3 represents methyl, and salts thereof.
Claim 7
Dependent Claim
9 words
N-acetyl-normuramyl-L-(N-methyl)-alanyl-D-isoglutamine .tbd.2-acetylamino-3-O-{[L-1-(D-1-carbamoyl-3-carboxy-propyl)-carbamoyl-ethyl]-N-methyl-carbamoylmethyl}-2-deoxy-D-glucose and salts thereof according to claim 1.
Claim 8
Dependent Claim
9 words
N-benzoyl-normuramyl-L-(N-ethyl)-α-amino-butyryl-D-isoglutamine .tbd.2-benzoylamino-3-O-{[L-1-(D-1-carbamoyl-3-carboxy-propyl)-carbamoyl-propyl]-N-ethyl-carbamoylmethyl}-2-deoxy-D-glucose and salts thereof according to claim 1.
Claim 9
Dependent Claim
9 words
N-acetyl-muramyl-L-(N-methyl)-α-aminobutyryl-D-isoglutamine .tbd.2-acetylamino-3-O-{D-1-[L-1-(D-1-carbamoyl-3-carboxy-propyl)-carbamoyl-propyl]-N-methyl-carbamoyl-ethyl}-2-deoxy-D-glucose and salts thereof according to claim 1.
Claim 10
Dependent Claim
10 words
N-acetyl-muramyl-L-(N-ethyl)-alanyl-D-isoglutamine .tbd. 2-acetylamino-3-O-{D-1-[L-1-(D-1-carbamoyl-3-carboxy-propyl)-carbamoyl-ethyl]-N-ethyl-carbamoyl-ethyl}-2-deoxy-D-glucose and salts thereof according to claim 1.
Claim 11
Dependent Claim
101 words
Compounds of the formula I according to claim 1 in which R 1 , R 4 and R 6 represent hydrogen, X represents carbonyl, R 2 represents lower alkyl which is unsubstituted or substituted by hydroxy or by methoxy, or phenyl which is unsubstituted or substituted by hydroxy, methoxy, methyl, ethyl or by halogen, R 3 and R 9 represent hydrogen or methyl, R 8 represents methyl, ethyl, n-propyl, isopropyl, 2-methylpropyl, methylmercaptomethyl, hydroxymethyl, hydroxyethyl, phenyl, benzyl or p-hydroxybenzyl, R 10 , R 11 and R 12 represent carboxy, lower alkoxycarbonyl or carbamoyl and R 11 also represents hydrogen, and salts thereof.
Claim 12
Dependent Claim
18 words
Compounds of the formula I according to claim 3, in which R 3 represents methyl, and salts thereof.
Claim 13
Dependent Claim
16 words
A compound according to claim 1, wherein R, R 4 , and R 6 are trimethylsilyl.
Claim 14
Dependent Claim
29 words
Pharmaceutical preparations for potentiating the immune-response of warm blooded animals, including man, containing an effective amount of a compound according to claim 1 together with a pharmaceutically acceptable carrier.
Claim 15
Dependent Claim
99 words
A pharmaceutical preparation according to claim 13, in which R 1 , R 4 and R 6 represent hydroen, X represents carbonyl, R 2 represents lower alkyl which is unsubstituted or substituted by hydroxy or by methoxy, or phenyl which is unsubstituted or substituted by hydroxy, methoxy, methyl, ethyl or by halogen, R 3 and R 9 represent hydrogen or methyl, R 8 represents methyl, ethyl, n-propyl, isopropyl, 2-methylpropyl, methylmercaptomethyl, hydroxymethyl, hydroxyethyl, phenyl, benzyl or p-hydroxybenzyl, R 10 , R 11 and R 12 represent carboxy, lower alkoxycarbonyl or carbamoyl and R 11 also represents hydrogen, and salts thereof.
Claim 16
Dependent Claim
69 words
A pharmaceutical preparation according to claim 13, in which R 1 , R 4 , R 6 , R 11 and R 13 represent hydrogen, R 2 represents methyl or phenyl, R 3 represents hydrogen or methyl, R 7 represents methyl, ethyl or propyl, R 8 represents hydrogen, methyl or ethyl, R 9 represents hydrogen, or methyl, R 10 represents carbamoyl and R 12 represents carboxy, and salts thereof.
Claim 17
Dependent Claim
19 words
A pharmaceutical preparation according to claim 13, in which R 7 is lower alkyl and R 13 is hydrogen.
Claim 18
Dependent Claim
16 words
A pharmaceutical preparation according to claim 15, in which R 3 is methyl, and salts thereof.
Claim 19
Dependent Claim
18 words
A compound according to claim 10, in which R 7 is lower alkyl and R 13 is hydrogen.
Claim 20
Dependent Claim
12 words
A compound according to claim 18, in which R 7 is methyl.
Claim 21
Dependent Claim
25 words
A method for potentiating the immune-response of warm blooded animals, including man, which comprises administering an effective amount of a compound according to claim 1.
Claim 22
Dependent Claim
25 words
A method for potentiating the immune-response of warm blooded animals, including man, which comprises administering an effective amount of a compound according to claim 10.
Claim 23
Dependent Claim
25 words
A method for potentiating the immune-response of warm blooded animals, including man, which comprises administering an effective amount of a compound according to claim 4.
Claim 24
Dependent Claim
25 words
A method for potentiating the immune-response of warm blooded animals, including man, which comprises administering an effective amount of a compound according to claim 18.
Claim 25
Dependent Claim
25 words
A method for potentiating the immune-response of warm blooded animals, including man, which comprises administering an effective amount of a compound according to claim 19.
References Cited (Backward Citations)
US4235771A
Cited
US4323559A
Cited
US4158052A
Cited
US4094971A
Cited
US4101649A
Cited
US4153684A
Cited
US4082736A
Cited
US4082735A
Cited
US4101536A
Cited
US4220637A
Cited
US4216208A
Cited
US4314998A
Cited
US4308202A
Cited
US4310514A
Cited
US4315913A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-08-08 | 1987-02-07 | 1987-08-09 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-08-08 | 1991-02-07 | 1991-08-09 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-08-08 | 1995-02-07 | 1995-08-09 | $7700.00 | Window Closed / Lapsed |